- Home
- SQM vs ICLR Comparison
SQM vs ICLR Comparison
Compare SQM & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQM
- ICLR
- Stock Information
- Founded
- SQM 1968
- ICLR 1990
- Country
- SQM Chile
- ICLR Ireland
- Employees
- SQM N/A
- ICLR N/A
- Industry
- SQM Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SQM Industrials
- ICLR Health Care
- Exchange
- SQM Nasdaq
- ICLR Nasdaq
- Market Cap
- SQM 9.9B
- ICLR 11.4B
- IPO Year
- SQM 1993
- ICLR 1998
- Fundamental
- Price
- SQM $30.42
- ICLR $130.28
- Analyst Decision
- SQM Buy
- ICLR Buy
- Analyst Count
- SQM 7
- ICLR 12
- Target Price
- SQM $41.86
- ICLR $204.18
- AVG Volume (30 Days)
- SQM 896.9K
- ICLR 1.6M
- Earning Date
- SQM 05-28-2025
- ICLR 07-23-2025
- Dividend Yield
- SQM N/A
- ICLR N/A
- EPS Growth
- SQM 53.25
- ICLR 11.53
- EPS
- SQM 2.11
- ICLR 9.19
- Revenue
- SQM $4,480,874,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- SQM N/A
- ICLR N/A
- Revenue Next Year
- SQM $20.12
- ICLR $2.34
- P/E Ratio
- SQM $14.42
- ICLR $14.18
- Revenue Growth
- SQM N/A
- ICLR N/A
- 52 Week Low
- SQM $30.18
- ICLR $125.10
- 52 Week High
- SQM $48.21
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- SQM 25.99
- ICLR 39.23
- Support Level
- SQM $32.61
- ICLR $125.10
- Resistance Level
- SQM $33.38
- ICLR $132.96
- Average True Range (ATR)
- SQM 0.90
- ICLR 4.34
- MACD
- SQM -0.31
- ICLR 0.79
- Stochastic Oscillator
- SQM 3.48
- ICLR 29.63
About SQM Sociedad Quimica y Minera S.A.
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM is developing a hard rock lithium project in Australia and expanding its lithium refining assets in China.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.